Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen
Clinical trial NCT01622062 · COMPLETED
Trial details
- NCT number
- NCT01622062
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-29
- Primary completion
- 2018-11-14
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.